结合CBCT观察食管癌肿瘤放疗后的靶区移位
Observation of Target Displacement of Esophageal Cancer after Radiotherapy Combined with CBCT
DOI: 10.12677/ACM.2022.124418, PDF,   
作者: 李 琛:山东大学,山东省肿瘤医院特需二病区,山东 济南;青岛大学附属烟台毓璜顶医院放疗科,山东 烟台;孟 雪:山东大学,山东省肿瘤医院特需二病区,山东 济南
关键词: 食管癌靶区移位容积旋转调强放疗千伏级锥形束计算机断层扫描图像引导的放射治疗Esophageal Cancer Target Displacement VMAT CBCT IGRT
摘要: 目的:探讨食管癌患者通过CBCT观察靶区在放疗过程中的移位规律,并找出较合适的CBCT频次。方法:取2017年11月至20年12月在烟台毓璜顶医院接受单纯放疗或放化疗患者85例,分别于放疗首次及之后每5次行CBCT扫描,在Aria系统中与原始定位图像以椎体为参照配准后,观察整个纵隔的位置变化,推断出靶区位置的相对变化。结果:共64例患者完成了CBCT扫描,其中,2例患者因为靶区位置变化较大进行了二次定位。CBCT显示放疗在第16次时出现整个疗程最大移位。结论:通过结合CBCT能反映出食管癌放疗患者放疗过程中的靶区位置变化并及时做出调整。放疗在第16次时,较易出现较大移位,需要多加注意。CBCT频次为每5次进行扫描,可以较早发现患者靶区位置变化并减少患者不必要的射线伤害。
Abstract: Objective: To investigate the displacement of target area in patients with esophageal cancer during radiotherapy by CBCT, and to find out a more appropriate frequency to carry out CBCT during a complete course of radiotherapy. Methods: Eight-five patients who received simple radiotherapy or chemo-radiotherapy in Yantai Yuhuangding Hospital from November 2017 to December 2020 were enrolled. CBCT scans were performed for the first time and every 5 times for the following treatment. The original positioning image was compared with the positioning image in the Aria system for reference, and the relative changes in the position of the entire mediastinum can be calculated according to the position of the target area. Results: A total of 64 patients completed all CBCT scannings, of which 2 patients underwent secondary localization due to tremendous change of the target location. CBCT showed that the maximum displacement of the whole course of radiotherapy occurred at the 16th time. Conclusion: CBCT reflects the changes of target position in patients with esophageal cancer during radiotherapy, and make adjustments in time. The combination of CBCT can reflect the changes in the target area during radiotherapy in patients with esophageal cancer and make timely adjustments. It was found that at the 16th time of radiotherapy, it is more likely to have a large shift, which means the preventive CBCT scan should be ordered for target displacement precaution.
文章引用:李琛, 孟雪. 结合CBCT观察食管癌肿瘤放疗后的靶区移位[J]. 临床医学进展, 2022, 12(4): 2904-2911. https://doi.org/10.12677/ACM.2022.124418

参考文献

[1] Thrumurthy, S.G., Asif Chaudry, M., Thrumurthy, S. and Mughal, M. (2018) Oesophageal Cancer: Risks, Prevention, and Diagnosis. BMJ, 366, Article ID: l4373. [Google Scholar] [CrossRef] [PubMed]
[2] Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-442. [Google Scholar] [CrossRef] [PubMed]
[3] 孟雪, 于金明. 食管癌放疗靶区勾画的原则及相关问题[J]. 中华肿瘤杂志, 2009, 31(11): 801-803.
[4] 吕海鹏, 王凯, 刘晓, 赵焕升, 胡范祥, 李翊. 中下段食管癌21例放疗不同呼吸时相正常组织剂量学研究[J]. 中华肿瘤防治杂志, 2020, 27(15): 1241-1246.
[5] Yoshio, K., Wakita, A., Mitsuhashi, T., Kitayama, T., Hisazumi, K., Inoue, D., et al. (2019) Simultaneous Integrated Boost Volumetric Modulatd Are Therapy for Middle or Lower Esophageal Cancer Using Elective Nodal Irradiation: Comparison with 3D Conformal Radiotherapy. Acta Medica Okayama, 73, 247-257. [Google Scholar] [CrossRef] [PubMed]
[6] 曹嘉伽, 周晓曦, 汤乐民. 胸中下段食管癌混合容积旋转调强放疗的剂量学比较[J]. 南通大学学报: 医学版, 2020, 40(5): 483-486.
[7] 徐裕金, 李浦, 胡晓, 王谨, 马红莲, 陈明. 螺旋断层、容积旋转调强和固定野调强在食管癌放疗剂量对比分析[J]. 中华医学杂志, 2019, 99(41): 3260-3265.
[8] 袁美芳, 赵彪, 杨毅, 汤可维, 安义均. 胸中段食管癌静态调强放疗与容积旋转调强放疗的靶区及危及器官的剂量学参数比较[J]. 实用临床医学杂志, 2020, 24(15): 21-24.
[9] Wang, L., Li, C., Meng, X., Li, C., Sun, X., Shang, D., et al. (2019) Dosimetric and Radiobiological Comparisob of External Beam Radiotherapy Using Simultaneous Integrated Boost Technique for Esophageal Cancer in Different Location. Frontiers in Oncology, 9, Article No. 674. [Google Scholar] [CrossRef] [PubMed]
[10] Bresciani, S., Botez, L., Miranti, A. and Stasi, M. (2019) PV-0484 in Vivo Dosimetiy Using CBCT and EPID Device: Analysis of Sources of Errors in VMAT Treatments. Radiotherapy and Oncology, 133, S249-S250. [Google Scholar] [CrossRef
[11] Gharzai, L., Verma, V., Denniston, K.A., Bhirud, A.R., Bennion, N.R. and Lin, C. (2016) Radiation Therapy and Cardiac Death in Long-Term Survivors of Esophageal Cancer: An Analysis of the Surveillance, Epidemiology, and End Result Database. PLoS ONE, 11, Article ID: 0158916. [Google Scholar] [CrossRef] [PubMed]
[12] Wilke, T.J., Bhirud, A.R. and Lin, C. (2015) A Review of the Impact of Preoperative Chemoradiotherapy on Outcome and Postoperative Complications in Esophageal Cancer Patients. American Journal of Clinical Oncology, 38, 415-421. [Google Scholar] [CrossRef
[13] Xi, M. and Lin, S.H. (2017) Recent Advances in Intensity Modulated Radiotherapy and Proton Therapy for Esophageal Cancer. Expert Review of Anticancer Therapy, 17, 635-646. [Google Scholar] [CrossRef] [PubMed]
[14] 彭小保, 陈文强, 赵军军, 袁慧杰, 徐晓婷. 食管癌调强技术根治性放疗后局部区域失败与靶区剂量体积关系研究[J]. 实用癌症杂志, 2017, 32(12): 1962-1966.
[15] 张安度, 韩晶, 韩春, 王澜, 孔洁, 张钧, 孔德友, 等. 食管鳞癌三维适形放疗剂量与疗效分析[J]. 中华肿瘤防治杂志, 2017, 24(10): 703-707.
[16] Boekhoff, M.R., Defize, I.L., Borggreve, A.S., Takahashi, N., van Lier, A.L.H.M.W., Ruurda, J.P., et al. (2020) 3-Dimensional Target Coverage Assessment for MRI Guided Esophageal Cancer Radiotherapy. Radiotherapy and Oncology, 147, 1-7. [Google Scholar] [CrossRef] [PubMed]
[17] Yang, S.N., Liao, C.Y., Chen, S.W., Liang, J.A., Tsai, M.H., Hua, C.H., et al. (2011) Clincial Implications of the Tumor Volume Reduction Rate in Head-and-Neck Cancer during Definitive Intensity-Modulated Radiotherapy for Organ Preservation. International Journal of Radiation Oncology, Biology, Physics, 79, 1096-1103. [Google Scholar] [CrossRef] [PubMed]
[18] Hong, T.S., Crowley, E.M., Killoran, J. and Mamon, H.J. (2006) Considerations in Treatment Planning for Esophageal Cancer. Seminars in Radiation Oncology, 17, 53-61. [Google Scholar] [CrossRef] [PubMed]
[19] Yaremko, B.P., Palma, D.A., Erickson, A.L., Pierce, G., Malthaner, R.A., Inculet, R.I., et al. (2013) Adjuvant Concurrent Chemoradiation Using Intensity-Modulated Radiotherapy and simultaneOus Integrated Boost for Resected High-Risk Adenocarcinoma of the Distal Esophagus and Gastro-Esophageal Junction. Radiation Oncology, 8, Article No. 33. [Google Scholar] [CrossRef
[20] Tang, H., Tang, C., Huang, H. (2014) Tumor Regression during IMRT Treatment for Esophageal Cancer and Its Clinical Value. The Practical Journal of Cancer, 29, 561-563.
[21] Doi, Y., Murakami, Y., Imano, N., Takeuchi, Y., Takahashi, I., Nishibuchi, I., et al. (2018) Quantifying Esophageal Motion during Free-Breathing and Breath-Hold Using Fiducial Markers in Patients with Early-Stage Esophageal Cancer. PLoS ONE, 13, Article ID: 0198844. [Google Scholar] [CrossRef] [PubMed]
[22] 张延军, 王凯, 马瑞, 王瑾瑜, 魏世鸿. 食管癌三维适形放射治疗中靶区移位的研究[J]. 国外医学(医学地理分册), 2019, 40(3): 286-289.
[23] 张延军, 王凯, 马瑞, 王瑾瑜, 魏世鸿, 谭子璇. 食管癌三维适形调强放疗过程中肿瘤区的移位及体积变化对其受照剂量的影响研究[J]. 实用医院临床杂志, 2021, 18(1): 15-19.
[24] 王奇峰, 章文成, 陈辛元, 章众, 韩伟, 杨阿立, 等. 食管癌简化调强放疗中靶体积变化及对初始计划剂量学影响[J]. 中华放射肿瘤学杂志, 2010, 19(6): 512-516.
[25] 王金之, 李建彬, 戚焕鹏, 张英杰, 范廷勇, 邵倩, 等. 基于放疗中重复四维CT的食管癌大体肿瘤体积与位移的相关性[J]. 中华放射肿瘤学杂志, 2014, 23(1): 36-39.